Our Story

Kinnos was founded to protect our healthcare workers and patients. During our junior year of college in October 2014, we joined Columbia's Ebola Design Challenge to fight the Ebola crisis in West Africa and the first prototype of Highlight® was born. Since then, we've recognized the urgent need to improve decontamination for both epidemic response and daily disinfection and the tangible impact Highlight® can have around the world. Our goal is to empower healthcare workers and patients to protect themselves and others, eliminate human error during decontamination, and prevent the unnecessary loss of life.

Learn more about our journey and progress on our blog.

Our Team

JASON KANG - Chief Executive officer, COFOUNDER

Jason Kang studied Biomedical Engineering at Columbia University as an Egleston Scholar and graduated Tau Beta Pi. Jason has previously conducted research at Harvard Medical School and Columbia University, worked on automating life sciences research at Transcriptic, and served as the VP of Engineering at Jibon Health Technologies, where he brought a medical device to clinical trials in Bangladesh. For his work in global health, Jason has served as a two-time U.S. Delegate at the Global Entrepreneurship Summit, Bluhm/Helfand Social Innovation Fellow, Kairos Society Fellow, and AAAS-Lemelson Invention Ambassador. Jason is also on the Board of Columbia Engineering Young Alumni.

KATHERINE JIN - Chief technology officer, COFOUNDER

Katherine Jin double-majored in Biology and Computer Science as a Coca-Cola Scholar at Columbia University. Katherine has worked in the Trauma Center and as a clinical researcher at Mount Sinai St. Luke's Hospital, and has conducted research at the Carnegie Institute of Washington and Columbia University. While at Columbia, Katherine served as Campus Coordinator of the Harlem Hospital Chapter of Health Leads. Katherine has been featured by the United Nations in celebration of International Day of Women and Girls in Science and was named to the inaugural list of The Tempest's #40WomentoWatch.

KEVIN TYAN - chief Scientific officer, COFOUNDER

Kevin Tyan graduated from Columbia University with Honors in Biology and is pursuing his M.D. at Harvard Medical School. Kevin has extensive experience in virology and immunology and conducted research at the National Institutes of Health, MedImmune-AstraZeneca, and Columbia University Medical Center. He previously led Columbia University's Emergency Medical Service. Kevin was featured at TEDMED as a Hive Innovator and was the Grand Prize winner in Harvard’s President’s Innovation Challenge.

Sarah Saatori - Lead Scientist

Sarah Saatori earned her M.S. in Chemistry from St. John’s University, where she also served as an Adjunct Professor in Chemistry. With a deep background in general, organic, micro and macro physical, instrumental, and analytical chemistry, Sarah leads product development at Kinnos. Sarah has presented at the American Chemical Society National Meeting and Gordon Research Conference, and first authored a paper in the Journal of Organic Chemistry.

Aaron Chong - Research Scientist

Aaron Chong is a Henry C. Enders fellow at The Cooper Union for the Advancement of Science and Art, where he is pursuing his M.E. in Chemical Engineering and has conducted research on the application of green solvents for chemical synthesis. With his broad background in the chemical sciences and process optimizations, Aaron is a key member of the product development team at Kinnos.

Advisory Board



National Emerging Infectious Diseases Laboratory

Assistant Professor of Medicine - Section of Infectious Diseases
Boston University School of Medicine



Director and Research Professor
Statewide Program for Infection Control and Epidemiology
UNC School of Medicine

Former Director
Hospital Epidemiology, Occupational Health and Safety Program
UNC Hospitals



Retired Research Director
The Clorox Company



Executive Vice President and Chief Technology Officer



Former Chief Executive Officer

Executive in Residence
Wyss Institute & Excel Venture Management



Chief Executive Officer
Velano Vascular